| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
GAB1 |
GAB1: GRB2-associated-binding protein 1 |
7.715 |
Evidence |
|
| ADAMDEC1 |
ADAMDEC1: ADAM DEC1 precursor |
ELA3B |
ELA3B: Elastase-3B precursor |
7.715 |
Evidence |
|
| EIF3S7 |
EIF3S7: Eukaryotic translation initiation factor 3 subunit 7 |
VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
7.68 |
Evidence |
O
|
| EIF3S5 |
IPI00011257 |
RPS10 |
RPS10: 40S ribosomal protein S10 |
7.68 |
Evidence |
|
| PIAS1 |
PIAS1, DDXBP1: E3 SUMO-protein ligase PIAS1 |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
7.68 |
Evidence |
|
| RGS19 |
RGS19, GAIP, GNAI3IP: Regulator of G-protein signaling 19 |
TSHR |
IPI00386365 |
7.667 |
Evidence |
|
| DCC |
DCC: Netrin receptor DCC precursor |
CRKL |
CRKL: Crk-like protein |
7.667 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
7.667 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
7.667 |
Evidence |
|
| PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
7.667 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
GRIK2 |
GRIK2, GLUR6: Glutamate receptor, ionotropic kainate 2 precursor |
7.667 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
THBS3 |
THBS3, TSP3: Thrombospondin-3 precursor |
7.667 |
Evidence |
|
| FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
7.667 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
7.667 |
Evidence |
|
| JUNB |
JUNB: Transcription factor jun-B |
PLA2G4A |
PLA2G4A, CPLA2, PLA2G4: Cytosolic phospholipase A2 |
7.632 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
PLA2G4A |
PLA2G4A, CPLA2, PLA2G4: Cytosolic phospholipase A2 |
7.632 |
Evidence |
|
| RANGAP1 |
RANGAP1, SD: Ran GTPase-activating protein 1 |
TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
7.63 |
Evidence |
|
| NBN |
NBN, NBS, NBS1, P95: Nibrin |
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
7.627 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
CSF3R |
IPI00216365 |
7.625 |
Evidence |
|
| TNFSF14 |
TNFSF14, HVEML, UNQ391/PRO726, LIGHT: Tumor necrosis factor ligand superfamily m |
F2 |
F2: Prothrombin precursor |
7.625 |
Evidence |
|
| ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
CCNB1 |
Cyclin B1 |
7.61 |
Evidence |
|
| CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
7.61 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
GRLF1 |
IPI00477498 |
7.61 |
Evidence |
|
| RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
7.61 |
Evidence |
|
| HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
ITIH4 |
ITIH4, IHRP, PRO1851, ITIHL1, PK120: Inter-alpha-trypsin inhibitor heavy chain H |
7.61 |
Evidence |
|